41 results on '"Borsato, C"'
Search Results
2. Physical activity as an adverse factor in the course of natural history in LGMD2B: SC315
3. Extracranial and intracranial vasoconstriction syndrome: an under-recognised cause of ischemic stroke: SC219
4. Spontaneous vasospasm and cerebral ischemia: Myth or reality?
5. Sphingomonas paucimobilis associated with localised calf myositis
6. A Multicentric Prospective Incidence Study of Guillain-Barré Syndrome in Italy. The ITANG Study
7. A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study
8. Dysferlinopathy course and sportive activity: clues for possible treatment
9. A standardized clinical evaluation of patients affected by facioscapulohumeralmuscular dystrophy: The FSHD clinical score
10. Muscle magnetic resonance spectroscopy (1H-MRS) in patients affected with LGMD2B
11. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score
12. Cognitive and neuroradiological profile in LGMD-2I
13. Spontaneous vasospasm and cerebral ischemia: Myth or reality?
14. Unexpected high percentage of asymptomatic subjects carrying the FSHD molecular defect: Which factors contribute to the disease mechanism?
15. A robust tool to quantify disability in patients affected by facioscapulohumeral muscular dystrophy
16. Presentation of a new DVD-based tool for the evaluation of patients with facioscapulohumeral muscula dystrophy (FSHD)
17. A robust tool to quantify disability in patients affected by facio-scapulo-humeral muscular dystrophy
18. Recurrent and migrant right internal carotid artery vasospasm after left internal carotid artery dissection
19. MRI muscle imaging pattern in myositis, an heterogenous inflammatory pathology of skeletal muscle
20. Psychopathologic and cognitive feauters in DM1 e 2
21. Myotonic dystrophy type 1. CTG triplet expansion re-tested after 10 years: molecular and clinical considerations
22. Does sport affect LGMD2B progression?
23. Case report: septin gene mutation in a sporadic case of hereditary neuralgic amyotrophy (HNA)
24. The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)
25. G.P.15.09 Unexpected high percentage of asymptomatic subjects carrying the FSHD molecular defect: Which factors contribute to the disease mechanism?
26. D.P.1.02 A robust tool to quantify disability in patients affected by facioscapulohumeral muscular dystrophy
27. D.P.1.04 Size and number of D4Z4 alleles play a role in FSHD phenotype
28. G.P.4.07 Relation between LGMD2B progression and physical activity
29. Dysferlinopathy course and sportive activity: Clues for possible treatment
30. Transient and recurrent CNS involvement in a 21-year-old man affected with CMT1X (Connexin-32)
31. Physical activity as an adverse factor in the course of natural history in LGMD2B
32. Serological inflammatory profile in LGMD2B: good or bad macrophage-muscle fiber interaction.?
33. MRI study of limb girdle muscular dystrophies and inflammatory myopathies
34. Comparison of muscle fiber atrophy in myasthenic patients with auto-antibodies against AChR and anti-MuSK
35. Cognitive profile in LGMD-2I
36. Dysferlinopathy course and sportive activity: clues for possible treatment
37. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score
38. Rapid onset of efficacy of rasagiline in early Parkinson's disease.
39. Dysferlinopathy course and sportive activity: clues for possible treatment.
40. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score.
41. MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.